To me this looks good, but I wonder what the market will make of this: “An uneven profit profile for CSL is expected for the first and second half results, due to the seasonality of the influenza business and the timing of expenses – particularly research and development,” Mr. Perreault added.
- Forums
- ASX - By Stock
- CSL
- Ann: Half Year Results Analyst Presentation
Ann: Half Year Results Analyst Presentation, page-3
-
-
- There are more pages in this discussion • 188 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
|
|||||
Last
$309.50 |
Change
-1.625(0.52%) |
Mkt cap ! $149.8B |
Open | High | Low | Value | Volume |
$308.37 | $311.14 | $307.33 | $301.9M | 1.021M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 12 | $309.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$309.57 | 84 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 70 | 309.330 |
2 | 15 | 309.320 |
1 | 18 | 309.310 |
1 | 3 | 309.300 |
2 | 48 | 309.290 |
Price($) | Vol. | No. |
---|---|---|
309.380 | 265 | 6 |
309.390 | 10 | 1 |
309.400 | 26 | 3 |
309.410 | 5 | 1 |
309.420 | 5 | 1 |
Last trade - 13.14pm 19/07/2024 (20 minute delay) ? |
Featured News
CSL (ASX) Chart |